Market Outlook
The global Alinia (nitazoxanide) market size was valued at USD 184.7 million in 2022 and is forecast to a readjusted size of USD 229.6 million by 2029 with a CAGR of 3.2% during review period.
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.
This report is a detailed and comprehensive analysis for global Alinia (nitazoxanide) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Alinia (nitazoxanide) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Alinia (nitazoxanide) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Alinia (nitazoxanide) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Alinia (nitazoxanide) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alinia (nitazoxanide)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alinia (nitazoxanide) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Romark Laboratories
Chugai Pharmaceutical
Lupin
Segmentation By Type
Tablets
Oral Suspension
Segmentation By Application
Retail Pharmacy
Hospital
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Alinia (nitazoxanide) market in 2025?
Alinia's strong clinical efficacy against a wide range of gastrointestinal infections and parasitic diseases gives it a significant edge in the market. Its broad-spectrum action, combined with its relatively low side-effect profile, contributes to high patient satisfaction and physician preference, driving demand.
What weaknesses could impact the Alinia (nitazoxanide) market in 2025?
A key weakness is its limited availability and relatively high cost compared to generic alternatives. Moreover, the drug’s niche application, focusing mainly on parasitic infections, restricts its broader market appeal compared to more general-purpose medications.
What opportunities exist for the Alinia (nitazoxanide) market in 2025?
There is a growing global focus on combating parasitic infections in developing regions, which presents a significant opportunity for expansion. Additionally, increasing awareness of antimicrobial resistance can open doors for Alinia as a promising treatment for infections that are becoming harder to treat with traditional antibiotics.
What threats could hinder the growth of the Alinia (nitazoxanide) market in 2025?
The main threat is the potential for new, more effective treatments to emerge, making Alinia less relevant. Competition from generics and other innovative treatments for parasitic and gastrointestinal infections could also pressure market share and pricing. Additionally, regulatory hurdles and pricing constraints in certain markets could slow growth.
Market PESTEL Analysis
What are the political factors influencing the Alinia (nitazoxanide) market in 2025?
Political stability in key markets, such as developing nations with high rates of parasitic infections, can drive demand for Alinia. Additionally, government healthcare policies and public health initiatives focusing on antimicrobial resistance may create opportunities for the drug.
How do economic factors impact the Alinia (nitazoxanide) market in 2025?
Economic conditions, particularly in emerging markets, play a significant role in shaping access to Alinia. Price sensitivity in low-income regions could limit the market's expansion, while higher healthcare spending in developed countries may enhance its reach and affordability.
What social factors are affecting the Alinia (nitazoxanide) market in 2025?
Increasing awareness about infectious diseases and the need for effective treatments, particularly in underserved areas, could drive demand for Alinia. Additionally, societal attitudes toward antimicrobial resistance may further boost interest in alternative therapies like nitazoxanide.
What technological factors influence the Alinia (nitazoxanide) market in 2025?
Advances in biotechnology and drug delivery systems could improve the effectiveness and convenience of Alinia, potentially expanding its market. However, the development of alternative treatments leveraging new technologies may also pose competition.
What environmental factors impact the Alinia (nitazoxanide) market in 2025?
Environmental concerns related to the disposal of pharmaceutical waste and the ecological impact of drug manufacturing processes could affect market dynamics. Moreover, sustainable production methods might become more crucial as the global focus on eco-friendly practices intensifies.
What legal factors affect the Alinia (nitazoxanide) market in 2025?
Regulatory approvals, patent protection, and pricing regulations will continue to shape the Alinia market. Legal challenges such as patent expirations or changes in healthcare reimbursement policies could also influence the drug's accessibility and market potential.
Market SIPOC Analysis
Who are the suppliers in the Alinia (nitazoxanide) market in 2025?
The suppliers in the Alinia market include manufacturers of raw materials, active pharmaceutical ingredients (APIs), and packaging companies. Pharmaceutical companies responsible for producing and distributing Alinia also play a key role as suppliers.
What are the inputs for the Alinia (nitazoxanide) market in 2025?
The inputs include the active ingredient nitazoxanide, raw materials for production, research and development data, manufacturing facilities, regulatory approvals, and marketing resources.
What are the processes involved in the Alinia (nitazoxanide) market in 2025?
The processes include drug formulation, clinical trials, regulatory approval, manufacturing, quality control, distribution, and marketing. Post-market surveillance and patient support programs also play key roles in the product lifecycle.
Who are the customers of the Alinia (nitazoxanide) market in 2025?
The customers include hospitals, healthcare providers, clinics, pharmacies, and government health organizations. Additionally, patients with parasitic infections or gastrointestinal diseases are direct consumers, often through prescriptions.
What are the outputs of the Alinia (nitazoxanide) market in 2025?
The outputs are the finished pharmaceutical product (Alinia tablets or oral suspension), therapeutic solutions for parasitic infections, and market-related data such as sales figures and healthcare outcomes. These outputs aim to improve patient health and address unmet medical needs in the global market.
Market Porter's Five Forces
What is the threat of new entrants in the Alinia (nitazoxanide) market in 2025?
The threat of new entrants is relatively low due to high barriers to entry, including stringent regulatory requirements, significant capital investment for research and development, and the need for established distribution channels. Alinia's existing market presence and patents also discourage new competitors.
What is the bargaining power of suppliers in the Alinia (nitazoxanide) market in 2025?
The bargaining power of suppliers is moderate. While raw materials for production are essential, the pharmaceutical industry has a range of suppliers for active ingredients. However, limited access to high-quality raw materials and specialized manufacturing facilities can increase supplier power.
What is the bargaining power of buyers in the Alinia (nitazoxanide) market in 2025?
The bargaining power of buyers is moderate to high, particularly in regions with competitive alternatives. In price-sensitive markets, healthcare providers and government agencies can exert pressure on pricing and accessibility. However, the specialized nature of Alinia and its effectiveness for specific infections gives it some leverage.
What is the threat of substitute products in the Alinia (nitazoxanide) market in 2025?
The threat of substitutes is moderate. While alternative treatments exist for parasitic infections and gastrointestinal diseases, few have the same broad-spectrum efficacy and low side-effect profile as Alinia. However, the emergence of new drugs or more affordable generics could pose a threat in the future.
What is the level of industry rivalry in the Alinia (nitazoxanide) market in 2025?
The level of industry rivalry is moderate. Alinia competes within a niche market, but there are other drugs addressing similar health issues. Large pharmaceutical companies with extensive portfolios may also bring competitive pressure, particularly if they develop better or more cost-effective alternatives.
Market Upstream Analysis
What are the key suppliers in the upstream of the Alinia (nitazoxanide) market in 2025?
Key suppliers include manufacturers of the active pharmaceutical ingredients (APIs), raw materials, and packaging materials. Additionally, research and development partners that provide clinical data and regulatory support also play an essential role in the upstream supply chain.
What raw materials are required for the production of Alinia (nitazoxanide)?
The primary raw materials include nitazoxanide (the active ingredient), excipients for tablet or suspension formulation, and packaging materials. The production process also requires specialized manufacturing equipment and quality control materials to ensure the drug’s safety and effectiveness.
What is the role of research and development in the upstream of the Alinia market in 2025?
R&D plays a crucial role in improving the formulation of Alinia, ensuring its efficacy, and complying with regulatory standards. Ongoing clinical trials and the development of new delivery mechanisms or improved versions of the drug also contribute to the product’s value in the market.
How do regulatory bodies influence the upstream of the Alinia market?
Regulatory bodies, such as the FDA, EMA, and others, influence the upstream by setting the standards for clinical trials, approval processes, and quality control. Compliance with these regulations is essential for ensuring that Alinia can be manufactured, marketed, and sold in global markets.
What challenges exist in the upstream of the Alinia (nitazoxanide) market in 2025?
Challenges in the upstream include the cost and availability of high-quality raw materials, compliance with changing regulatory requirements, and the complexity of manufacturing processes. Additionally, ensuring that production scales effectively to meet demand, particularly in developing markets, can pose logistical and financial challenges.
Market Midstream Analysis
What are the key processes involved in the midstream of the Alinia (nitazoxanide) market in 2025?
The key processes include manufacturing, packaging, and quality control. After the raw materials are sourced, the drug undergoes production at certified facilities, followed by rigorous testing to ensure safety and efficacy. Packaging then takes place, ensuring the drug is ready for distribution.
How do distributors impact the midstream of the Alinia market?
Distributors play a crucial role in ensuring Alinia reaches healthcare providers, hospitals, clinics, and pharmacies. They handle the logistics of transporting the drug across various regions, ensuring it remains accessible to patients. Strong partnerships with distributors are essential for maintaining market reach.
What role do regulatory approvals play in the midstream of the Alinia market?
Regulatory approvals are critical in the midstream process as they ensure that each batch of Alinia meets the required standards for quality and safety. Compliance with regional and international regulations is mandatory before the drug can be marketed and distributed, influencing production timelines and costs.
How do pricing strategies affect the midstream of the Alinia market?
Pricing strategies directly influence the affordability and competitiveness of Alinia in the market. The cost of manufacturing, regulatory fees, and distribution logistics all factor into pricing decisions. Additionally, in price-sensitive regions, strategic pricing and reimbursement negotiations play a key role in access to the drug.
What challenges does the midstream face in the Alinia market?
Challenges in the midstream include supply chain disruptions, maintaining consistent product quality, and navigating complex regulatory environments. Additionally, fluctuating demand across regions and managing the costs of distribution in diverse markets can impact overall efficiency and profitability.
Market Downstream Analysis
What are the key components in the downstream of the Alinia (nitazoxanide) market in 2025?
The key components in the downstream include marketing, sales, customer support, and post-market surveillance. These processes ensure that Alinia reaches its target markets, is effectively promoted to healthcare providers, and is monitored for long-term patient outcomes.
How do healthcare providers and pharmacists influence the downstream of the Alinia market?
Healthcare providers and pharmacists are essential in prescribing and dispensing Alinia to patients. Their knowledge of the drug's efficacy and safety influences patient access and adoption. Strong relationships with healthcare professionals are critical for driving usage and ensuring patient compliance.
What role does patient access and affordability play in the downstream of the Alinia market?
Patient access and affordability are key drivers in the downstream. Effective distribution networks and patient assistance programs can improve access, especially in low-income regions. Pricing strategies, insurance coverage, and reimbursement policies also play a significant role in patient uptake.
How does marketing and promotion impact the downstream of the Alinia market?
Marketing and promotion are crucial in raising awareness about Alinia’s benefits among healthcare providers and patients. Effective campaigns, educational initiatives, and detailing to physicians help establish Alinia as a preferred treatment, which can directly impact sales and market share.
What challenges exist in the downstream of the Alinia (nitazoxanide) market?
Challenges include market competition from generics and other alternative treatments, regulatory restrictions on advertising, and pricing pressures. Additionally, patient adherence to prescribed treatments and ensuring availability in remote or underserved regions can limit the drug’s effectiveness in reaching its full potential.
Chapter 1, to describe Alinia (nitazoxanide) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alinia (nitazoxanide), with price, sales, revenue and global market share of Alinia (nitazoxanide) from 2018 to 2023.
Chapter 3, the Alinia (nitazoxanide) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alinia (nitazoxanide) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Alinia (nitazoxanide) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alinia (nitazoxanide).
Chapter 14 and 15, to describe Alinia (nitazoxanide) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Alinia (nitazoxanide)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Alinia (nitazoxanide) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablets
1.3.3 Oral Suspension
1.4 Market Analysis by Application
1.4.1 Overview: Global Alinia (nitazoxanide) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Retail Pharmacy
1.4.3 Hospital
1.4.4 Others
1.5 Global Alinia (nitazoxanide) Market Size & Forecast
1.5.1 Global Alinia (nitazoxanide) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Alinia (nitazoxanide) Sales Quantity (2018-2029)
1.5.3 Global Alinia (nitazoxanide) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Romark Laboratories
2.1.1 Romark Laboratories Details
2.1.2 Romark Laboratories Major Business
2.1.3 Romark Laboratories Alinia (nitazoxanide) Product and Services
2.1.4 Romark Laboratories Alinia (nitazoxanide) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Romark Laboratories Recent Developments/Updates
2.2 Chugai Pharmaceutical
2.2.1 Chugai Pharmaceutical Details
2.2.2 Chugai Pharmaceutical Major Business
2.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Product and Services
2.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Chugai Pharmaceutical Recent Developments/Updates
2.3 Lupin
2.3.1 Lupin Details
2.3.2 Lupin Major Business
2.3.3 Lupin Alinia (nitazoxanide) Product and Services
2.3.4 Lupin Alinia (nitazoxanide) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lupin Recent Developments/Updates
3 Competitive Environment: Alinia (nitazoxanide) by Manufacturer
3.1 Global Alinia (nitazoxanide) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Alinia (nitazoxanide) Revenue by Manufacturer (2018-2023)
3.3 Global Alinia (nitazoxanide) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Alinia (nitazoxanide) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Alinia (nitazoxanide) Manufacturer Market Share in 2022
3.4.2 Top 6 Alinia (nitazoxanide) Manufacturer Market Share in 2022
3.5 Alinia (nitazoxanide) Market: Overall Company Footprint Analysis
3.5.1 Alinia (nitazoxanide) Market: Region Footprint
3.5.2 Alinia (nitazoxanide) Market: Company Product Type Footprint
3.5.3 Alinia (nitazoxanide) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Alinia (nitazoxanide) Market Size by Region
4.1.1 Global Alinia (nitazoxanide) Sales Quantity by Region (2018-2029)
4.1.2 Global Alinia (nitazoxanide) Consumption Value by Region (2018-2029)
4.1.3 Global Alinia (nitazoxanide) Average Price by Region (2018-2029)
4.2 North America Alinia (nitazoxanide) Consumption Value (2018-2029)
4.3 Europe Alinia (nitazoxanide) Consumption Value (2018-2029)
4.4 Asia-Pacific Alinia (nitazoxanide) Consumption Value (2018-2029)
4.5 South America Alinia (nitazoxanide) Consumption Value (2018-2029)
4.6 Middle East and Africa Alinia (nitazoxanide) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Alinia (nitazoxanide) Sales Quantity by Type (2018-2029)
5.2 Global Alinia (nitazoxanide) Consumption Value by Type (2018-2029)
5.3 Global Alinia (nitazoxanide) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Alinia (nitazoxanide) Sales Quantity by Application (2018-2029)
6.2 Global Alinia (nitazoxanide) Consumption Value by Application (2018-2029)
6.3 Global Alinia (nitazoxanide) Average Price by Application (2018-2029)
7 North America
7.1 North America Alinia (nitazoxanide) Sales Quantity by Type (2018-2029)
7.2 North America Alinia (nitazoxanide) Sales Quantity by Application (2018-2029)
7.3 North America Alinia (nitazoxanide) Market Size by Country
7.3.1 North America Alinia (nitazoxanide) Sales Quantity by Country (2018-2029)
7.3.2 North America Alinia (nitazoxanide) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Alinia (nitazoxanide) Sales Quantity by Type (2018-2029)
8.2 Europe Alinia (nitazoxanide) Sales Quantity by Application (2018-2029)
8.3 Europe Alinia (nitazoxanide) Market Size by Country
8.3.1 Europe Alinia (nitazoxanide) Sales Quantity by Country (2018-2029)
8.3.2 Europe Alinia (nitazoxanide) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Alinia (nitazoxanide) Market Size by Region
9.3.1 Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Alinia (nitazoxanide) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Alinia (nitazoxanide) Sales Quantity by Type (2018-2029)
10.2 South America Alinia (nitazoxanide) Sales Quantity by Application (2018-2029)
10.3 South America Alinia (nitazoxanide) Market Size by Country
10.3.1 South America Alinia (nitazoxanide) Sales Quantity by Country (2018-2029)
10.3.2 South America Alinia (nitazoxanide) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Alinia (nitazoxanide) Market Size by Country
11.3.1 Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Alinia (nitazoxanide) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Alinia (nitazoxanide) Market Drivers
12.2 Alinia (nitazoxanide) Market Restraints
12.3 Alinia (nitazoxanide) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Alinia (nitazoxanide) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Alinia (nitazoxanide)
13.3 Alinia (nitazoxanide) Production Process
13.4 Alinia (nitazoxanide) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Alinia (nitazoxanide) Typical Distributors
14.3 Alinia (nitazoxanide) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Alinia (nitazoxanide) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Alinia (nitazoxanide) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Romark Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Romark Laboratories Major Business
Table 5. Romark Laboratories Alinia (nitazoxanide) Product and Services
Table 6. Romark Laboratories Alinia (nitazoxanide) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Romark Laboratories Recent Developments/Updates
Table 8. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Chugai Pharmaceutical Major Business
Table 10. Chugai Pharmaceutical Alinia (nitazoxanide) Product and Services
Table 11. Chugai Pharmaceutical Alinia (nitazoxanide) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Chugai Pharmaceutical Recent Developments/Updates
Table 13. Lupin Basic Information, Manufacturing Base and Competitors
Table 14. Lupin Major Business
Table 15. Lupin Alinia (nitazoxanide) Product and Services
Table 16. Lupin Alinia (nitazoxanide) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lupin Recent Developments/Updates
Table 18. Global Alinia (nitazoxanide) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 19. Global Alinia (nitazoxanide) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 20. Global Alinia (nitazoxanide) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Market Position of Manufacturers in Alinia (nitazoxanide), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 22. Head Office and Alinia (nitazoxanide) Production Site of Key Manufacturer
Table 23. Alinia (nitazoxanide) Market: Company Product Type Footprint
Table 24. Alinia (nitazoxanide) Market: Company Product Application Footprint
Table 25. Alinia (nitazoxanide) New Market Entrants and Barriers to Market Entry
Table 26. Alinia (nitazoxanide) Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Alinia (nitazoxanide) Sales Quantity by Region (2018-2023) & (K Units)
Table 28. Global Alinia (nitazoxanide) Sales Quantity by Region (2024-2029) & (K Units)
Table 29. Global Alinia (nitazoxanide) Consumption Value by Region (2018-2023) & (USD Million)
Table 30. Global Alinia (nitazoxanide) Consumption Value by Region (2024-2029) & (USD Million)
Table 31. Global Alinia (nitazoxanide) Average Price by Region (2018-2023) & (US$/Unit)
Table 32. Global Alinia (nitazoxanide) Average Price by Region (2024-2029) & (US$/Unit)
Table 33. Global Alinia (nitazoxanide) Sales Quantity by Type (2018-2023) & (K Units)
Table 34. Global Alinia (nitazoxanide) Sales Quantity by Type (2024-2029) & (K Units)
Table 35. Global Alinia (nitazoxanide) Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Global Alinia (nitazoxanide) Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Global Alinia (nitazoxanide) Average Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Alinia (nitazoxanide) Average Price by Type (2024-2029) & (US$/Unit)
Table 39. Global Alinia (nitazoxanide) Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Alinia (nitazoxanide) Sales Quantity by Application (2024-2029) & (K Units)
Table 41. Global Alinia (nitazoxanide) Consumption Value by Application (2018-2023) & (USD Million)
Table 42. Global Alinia (nitazoxanide) Consumption Value by Application (2024-2029) & (USD Million)
Table 43. Global Alinia (nitazoxanide) Average Price by Application (2018-2023) & (US$/Unit)
Table 44. Global Alinia (nitazoxanide) Average Price by Application (2024-2029) & (US$/Unit)
Table 45. North America Alinia (nitazoxanide) Sales Quantity by Type (2018-2023) & (K Units)
Table 46. North America Alinia (nitazoxanide) Sales Quantity by Type (2024-2029) & (K Units)
Table 47. North America Alinia (nitazoxanide) Sales Quantity by Application (2018-2023) & (K Units)
Table 48. North America Alinia (nitazoxanide) Sales Quantity by Application (2024-2029) & (K Units)
Table 49. North America Alinia (nitazoxanide) Sales Quantity by Country (2018-2023) & (K Units)
Table 50. North America Alinia (nitazoxanide) Sales Quantity by Country (2024-2029) & (K Units)
Table 51. North America Alinia (nitazoxanide) Consumption Value by Country (2018-2023) & (USD Million)
Table 52. North America Alinia (nitazoxanide) Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Europe Alinia (nitazoxanide) Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Europe Alinia (nitazoxanide) Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Europe Alinia (nitazoxanide) Sales Quantity by Application (2018-2023) & (K Units)
Table 56. Europe Alinia (nitazoxanide) Sales Quantity by Application (2024-2029) & (K Units)
Table 57. Europe Alinia (nitazoxanide) Sales Quantity by Country (2018-2023) & (K Units)
Table 58. Europe Alinia (nitazoxanide) Sales Quantity by Country (2024-2029) & (K Units)
Table 59. Europe Alinia (nitazoxanide) Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Alinia (nitazoxanide) Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Type (2018-2023) & (K Units)
Table 62. Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Type (2024-2029) & (K Units)
Table 63. Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Application (2018-2023) & (K Units)
Table 64. Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Application (2024-2029) & (K Units)
Table 65. Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Region (2018-2023) & (K Units)
Table 66. Asia-Pacific Alinia (nitazoxanide) Sales Quantity by Region (2024-2029) & (K Units)
Table 67. Asia-Pacific Alinia (nitazoxanide) Consumption Value by Region (2018-2023) & (USD Million)
Table 68. Asia-Pacific Alinia (nitazoxanide) Consumption Value by Region (2024-2029) & (USD Million)
Table 69. South America Alinia (nitazoxanide) Sales Quantity by Type (2018-2023) & (K Units)
Table 70. South America Alinia (nitazoxanide) Sales Quantity by Type (2024-2029) & (K Units)
Table 71. South America Alinia (nitazoxanide) Sales Quantity by Application (2018-2023) & (K Units)
Table 72. South America Alinia (nitazoxanide) Sales Quantity by Application (2024-2029) & (K Units)
Table 73. South America Alinia (nitazoxanide) Sales Quantity by Country (2018-2023) & (K Units)
Table 74. South America Alinia (nitazoxanide) Sales Quantity by Country (2024-2029) & (K Units)
Table 75. South America Alinia (nitazoxanide) Consumption Value by Country (2018-2023) & (USD Million)
Table 76. South America Alinia (nitazoxanide) Consumption Value by Country (2024-2029) & (USD Million)
Table 77. Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Type (2018-2023) & (K Units)
Table 78. Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Type (2024-2029) & (K Units)
Table 79. Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Region (2018-2023) & (K Units)
Table 82. Middle East & Africa Alinia (nitazoxanide) Sales Quantity by Region (2024-2029) & (K Units)
Table 83. Middle East & Africa Alinia (nitazoxanide) Consumption Value by Region (2018-2023) & (USD Million)
Table 84. Middle East & Africa Alinia (nitazoxanide) Consumption Value by Region (2024-2029) & (USD Million)
Table 85. Alinia (nitazoxanide) Raw Material
Table 86. Key Manufacturers of Alinia (nitazoxanide) Raw Materials
Table 87. Alinia (nitazoxanide) Typical Distributors
Table 88. Alinia (nitazoxanide) Typical Customers
List of Figures
Figure 1. Alinia (nitazoxanide) Picture
Figure 2. Global Alinia (nitazoxanide) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Alinia (nitazoxanide) Consumption Value Market Share by Type in 2022
Figure 4. Tablets Examples
Figure 5. Oral Suspension Examples
Figure 6. Global Alinia (nitazoxanide) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Alinia (nitazoxanide) Consumption Value Market Share by Application in 2022
Figure 8. Retail Pharmacy Examples
Figure 9. Hospital Examples
Figure 10. Others Examples
Figure 11. Global Alinia (nitazoxanide) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Alinia (nitazoxanide) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Alinia (nitazoxanide) Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Alinia (nitazoxanide) Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Alinia (nitazoxanide) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Alinia (nitazoxanide) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Alinia (nitazoxanide) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Alinia (nitazoxanide) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Alinia (nitazoxanide) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Alinia (nitazoxanide) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Alinia (nitazoxanide) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Alinia (nitazoxanide) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Alinia (nitazoxanide) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Alinia (nitazoxanide) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Alinia (nitazoxanide) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Alinia (nitazoxanide) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Alinia (nitazoxanide) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Alinia (nitazoxanide) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Alinia (nitazoxanide) Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Alinia (nitazoxanide) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Alinia (nitazoxanide) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Alinia (nitazoxanide) Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Alinia (nitazoxanide) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Alinia (nitazoxanide) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Alinia (nitazoxanide) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Alinia (nitazoxanide) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Alinia (nitazoxanide) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Alinia (nitazoxanide) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Alinia (nitazoxanide) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Alinia (nitazoxanide) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Alinia (nitazoxanide) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Alinia (nitazoxanide) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Alinia (nitazoxanide) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Alinia (nitazoxanide) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Alinia (nitazoxanide) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Alinia (nitazoxanide) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Alinia (nitazoxanide) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Alinia (nitazoxanide) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Alinia (nitazoxanide) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Alinia (nitazoxanide) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Alinia (nitazoxanide) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Alinia (nitazoxanide) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Alinia (nitazoxanide) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Alinia (nitazoxanide) Market Drivers
Figure 74. Alinia (nitazoxanide) Market Restraints
Figure 75. Alinia (nitazoxanide) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Alinia (nitazoxanide) in 2022
Figure 78. Manufacturing Process Analysis of Alinia (nitazoxanide)
Figure 79. Alinia (nitazoxanide) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
